AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
61 hedge funds and large institutions have $61.4M invested in Agile Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+15
Holders Change %
+32.61%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
17
Reduced
10
Closed
11
Calls
$1.03M
Puts
$294K
Net Calls
+$734K
Net Calls Change
+$365K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$7.44M |
| 2 |
Millennium Management
New York
|
+$2.38M |
| 3 |
O
OrbiMed
New York
|
+$2.23M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.48M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$930K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$4.23M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.22M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$819K |
| 4 |
EP
Eversept Partners
New York
|
-$788K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$225K |
